Astera Labs (NASDAQ:ALAB) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Astera Labs (NASDAQ:ALAB) from a hold rating to a buy rating in a research report sent to investors on Saturday.

ALAB has been the topic of a number of other research reports. Jefferies Financial Group increased their price target on shares of Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, July 22nd. Morgan Stanley increased their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a research note on Friday, August 29th. CICC Research started coverage on shares of Astera Labs in a research note on Friday, August 29th. They set an “outperform” rating and a $190.00 price target on the stock. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Citigroup increased their price target on shares of Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $162.06.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $156.31 on Friday. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The firm’s 50 day moving average price is $199.22 and its 200 day moving average price is $129.53. The firm has a market cap of $25.98 billion, a P/E ratio of 279.13, a price-to-earnings-growth ratio of 3.98 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the business earned $0.13 earnings per share. Astera Labs’s revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts predict that Astera Labs will post 0.34 EPS for the current year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jitendra Mohan sold 152,517 shares of Astera Labs stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the sale, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This trade represents a 25.31% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Great Valley Advisor Group Inc. boosted its holdings in shares of Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after buying an additional 90 shares during the period. Straight Path Wealth Management boosted its holdings in shares of Astera Labs by 1.5% in the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after buying an additional 100 shares during the period. First Horizon Advisors Inc. lifted its position in Astera Labs by 12.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after purchasing an additional 108 shares during the last quarter. Merit Financial Group LLC lifted its position in Astera Labs by 3.1% in the 3rd quarter. Merit Financial Group LLC now owns 5,683 shares of the company’s stock valued at $1,113,000 after purchasing an additional 170 shares during the last quarter. Finally, Advisors Asset Management Inc. lifted its position in Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.